Keurig Dr Pepper (NASDAQ:KDP) Research Coverage Started at BNP Paribas

Equities research analysts at BNP Paribas assumed coverage on shares of Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) in a research note issued to investors on Monday, MarketBeat Ratings reports. The firm set a “neutral” rating and a $36.00 price target on the stock. BNP Paribas’ target price suggests a potential upside of 3.84% from the stock’s previous close.

Get Keurig Dr Pepper alerts:

A number of other research analysts also recently issued reports on KDP. UBS Group raised their price target on shares of Keurig Dr Pepper from $39.00 to $40.00 and gave the stock a “buy” rating in a research report on Monday, June 10th. Morgan Stanley lowered their price objective on shares of Keurig Dr Pepper from $37.00 to $34.00 and set an “equal weight” rating on the stock in a research note on Monday, February 26th. Truist Financial raised shares of Keurig Dr Pepper from a “sell” rating to a “hold” rating and lifted their price objective for the stock from $27.00 to $34.00 in a research note on Monday, June 17th. Wells Fargo & Company lifted their target price on shares of Keurig Dr Pepper from $39.00 to $41.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 5th. Finally, Wedbush dropped their target price on shares of Keurig Dr Pepper from $37.00 to $35.00 and set an “outperform” rating on the stock in a research report on Monday, February 26th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, Keurig Dr Pepper currently has an average rating of “Moderate Buy” and an average price target of $36.57.

View Our Latest Report on Keurig Dr Pepper

Keurig Dr Pepper Trading Up 0.8 %

NASDAQ:KDP traded up $0.29 during trading hours on Monday, reaching $34.67. 7,818,478 shares of the company were exchanged, compared to its average volume of 9,380,006. Keurig Dr Pepper has a 52-week low of $27.66 and a 52-week high of $35.00. The stock has a 50 day simple moving average of $33.60 and a 200 day simple moving average of $32.03. The firm has a market cap of $47.00 billion, a price-to-earnings ratio of 22.19, a PEG ratio of 2.59 and a beta of 0.61. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.51 and a quick ratio of 0.34.

Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last released its quarterly earnings results on Thursday, April 25th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.04. The business had revenue of $3.47 billion during the quarter, compared to analyst estimates of $3.41 billion. Keurig Dr Pepper had a net margin of 14.52% and a return on equity of 10.18%. The business’s revenue was up 3.4% on a year-over-year basis. During the same period last year, the business earned $0.34 EPS. As a group, analysts predict that Keurig Dr Pepper will post 1.92 EPS for the current year.

Insider Transactions at Keurig Dr Pepper

In other news, insider Matthew Andrew Archambault sold 8,000 shares of the company’s stock in a transaction dated Thursday, May 23rd. The shares were sold at an average price of $34.19, for a total value of $273,520.00. Following the sale, the insider now owns 12,565 shares of the company’s stock, valued at approximately $429,597.35. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, insider Patrick Minogue sold 17,293 shares of the company’s stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $33.59, for a total value of $580,871.87. Following the sale, the insider now owns 67,103 shares of the company’s stock, valued at approximately $2,253,989.77. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Matthew Andrew Archambault sold 8,000 shares of the company’s stock in a transaction dated Thursday, May 23rd. The stock was sold at an average price of $34.19, for a total transaction of $273,520.00. Following the transaction, the insider now owns 12,565 shares in the company, valued at approximately $429,597.35. The disclosure for this sale can be found here. In the last quarter, insiders have sold 81,520 shares of company stock valued at $2,750,739. 1.00% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Turtle Creek Wealth Advisors LLC acquired a new position in Keurig Dr Pepper during the 4th quarter worth about $29,000. Bruce G. Allen Investments LLC acquired a new position in Keurig Dr Pepper during the 4th quarter worth about $34,000. Mather Group LLC. acquired a new position in Keurig Dr Pepper during the 1st quarter worth about $45,000. EverSource Wealth Advisors LLC lifted its position in Keurig Dr Pepper by 122.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 1,367 shares of the company’s stock worth $46,000 after buying an additional 753 shares in the last quarter. Finally, Ulland Investment Advisors LLC acquired a new position in Keurig Dr Pepper during the 4th quarter worth about $50,000. Institutional investors and hedge funds own 85.23% of the company’s stock.

Keurig Dr Pepper Company Profile

(Get Free Report)

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.

Should you invest $1,000 in Keurig Dr Pepper right now?

Before you consider Keurig Dr Pepper, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Keurig Dr Pepper wasn’t on the list.

While Keurig Dr Pepper currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today’s market? Click the link below and we’ll send you MarketBeat’s list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report